Related Experiment Videos
The pharmacological basis of treatment with high dose corticosteroids in circulatory shock
Insights
High-dose corticosteroids (HDC) impact shock pathophysiology, affecting circulation and metabolism. More research is needed on HDC pharmacokinetics, though methylprednisolone has a short half-life.
Area of Science:
- Pharmacology
- Critical Care Medicine
- Biochemistry
Background:
- Most studies on high-dose corticosteroids (HDC) in circulatory shock are descriptive.
- Existing research offers insights into HDC mechanisms of action and pharmacodynamics in shock.
- HDC influence cell membranes, granulocyte aggregation, oxygen delivery, circulation, and metabolism.
Purpose of the Study:
- To review the current understanding of high-dose corticosteroids in circulatory shock.
- To highlight the limited knowledge regarding HDC pharmacokinetics.
- To summarize known information on HDC pharmacodynamics and metabolism.
Main Methods:
- Literature review of published studies on HDC in circulatory shock.
- Analysis of research focusing on pharmacodynamics and mechanisms of action.
- Inclusion of data on pharmacokinetics, specifically elimination half-life and metabolism.
Main Results:
- HDC demonstrate significant effects on various pathophysiological processes in shock.
- Pharmacodynamic actions include modulation of cell stability and inflammatory responses.
- Pharmacokinetic data, particularly for methylprednisolone, indicate a short elimination half-life (2.4-3.5 hours) and hepatic metabolism.
Conclusions:
- HDC play a role in managing circulatory shock through diverse mechanisms.
- Further investigation into HDC pharmacokinetics is crucial for optimizing treatment strategies.
- Understanding HDC's full pharmacokinetic and pharmacodynamic profile is essential for clinical application.
Abstract:
It is evident that the majority of studies concerning the use of high dose corticosteroids (HDC) in circulatory shock hitherto published, in a pharmacological sense, are mainly descriptive. However, some of the studies have none the less provided valuable information about the mechanisms of action and a few investigations have primarily been designed to study the pharmacodynamics of HDC in different shock settings. The research has shown that HDC interferes with various pathophysiological mechanisms including cell membrane stability, granulocyte aggregability, oxygen delivery, peripheral circulation and metabolism. Less is known about the pharmacokinetics of HDC, a subject which has been more or less neglected until very recently. However, some basic facts are known. Hence, the mean elimination half life of methylprednisolone (MP) administered i.v. ranges from 2.4 to 3.5 hours in normal healthy adults. The drug is distributed widely throughout the body including the central nervous system and is metabolized mainly in the liver to inactive metabolites.